Jinyu Bio-technology saw the highest growth of 2.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Jinyu Bio-technology’s patent filings and grants. Buy the databook here.
Jinyu Bio-technology has been focused on protecting inventions in China(CN) with four publications in Q2 2024
The China(CN) Patent Office dominates the patent filings with nearly 100% of filings. The China(CN) patent Office are among the top ten patent offices where Jinyu Bio-technology is filings its patents..
GSK could be the strongest competitor for Jinyu Bio-technology
For comprehensive analysis of Jinyu Bio-technology's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.